These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31004607)

  • 21. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
    Ansalone G; Ricci R; Cacciatore G; Santini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis.
    AlTurki A; Proietti R; Alturki H; Essebag V; Huynh T
    Hellenic J Cardiol; 2019; 60(5):276-281. PubMed ID: 29292244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Kutyifa V; Kloppe A; Zareba W; Solomon SD; McNitt S; Polonsky S; Barsheshet A; Merkely B; Lemke B; Nagy VK; Moss AJ; Goldenberg I
    J Am Coll Cardiol; 2013 Mar; 61(9):936-44. PubMed ID: 23449428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.
    Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C
    Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac device therapy in patients with left ventricular dysfunction and heart failure: 'real-world' data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital).
    Boriani G; Berti E; Belotti LM; Biffi M; De Palma R; Malavasi VL; Bottoni N; Rossi L; De Maria E; Mantovan R; Zardini M; Casali E; Marconi M; Bandini A; Tomasi C; Boggian G; Barbato G; Toselli T; Zennaro M; Sassone B;
    Eur J Heart Fail; 2016 Jun; 18(6):693-702. PubMed ID: 27060289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy?
    Vaduganathan M; Patel RB; Shah SJ; Butler J
    Heart Fail Rev; 2016 Jul; 21(4):455-62. PubMed ID: 26762335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newer Indications for ICD and CRT.
    Merriam JA; Rajendra AB; Gold MR
    Cardiol Clin; 2014 May; 32(2):181-90. PubMed ID: 24793795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current challenges in sudden cardiac death prevention.
    Corrado D; Zorzi A; Vanoli E; Gronda E
    Heart Fail Rev; 2020 Jan; 25(1):99-106. PubMed ID: 31346843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac resynchronization therapy and its potential proarrhythmic effect.
    Basu Ray I; Fendelander L; Singh JP
    Clin Cardiol; 2007 Oct; 30(10):498-502. PubMed ID: 17823906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac resynchronization improves heart failure in one patient with myotonic dystrophy type 1. A case report.
    Russo V; Rago A; Antonio Papa A; Nigro G
    Acta Myol; 2012 Oct; 31(2):154-5. PubMed ID: 23097608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
    Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Implications of Complete Left-Sided Reverse Remodeling With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy.
    Mathias A; Moss AJ; McNitt S; Zareba W; Goldenberg I; Solomon SD; Kutyifa V
    J Am Coll Cardiol; 2016 Sep; 68(12):1268-76. PubMed ID: 27634117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
    Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
    Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Multivariate Risk Estimation Models to Predict Prognosis in Patients With Implantable Cardioverter Defibrillators With or Without Cardiac Resynchronization Therapy.
    Akoudad S; Dabiri Abkenari L; Schaer BA; Sticherling C; Levy WC; Jordaens L; Theuns DA
    Am J Cardiol; 2017 May; 119(9):1414-1420. PubMed ID: 28267958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ;
    Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.